ABOS
Acumen Pharmaceuticals, Inc.
Phase 1
AI-extracted
sabirnetug (ACU193)
Alzheimer's Disease
463d ago
~ Mar 31, 2025
SEC 8-K
verified 14h ago
Countdown card โ